Inflammatory bowel disease (IBD), which affects as many as 1 million Americans, refers to two chronic diseases that cause inflammation of the intestines: Crohn's disease and ulcerative colitis.
影响着一百万多美国人的炎症性肠病，是指能引起肠部炎症的两种慢性病：克罗恩氏病和溃疡性结肠炎。
UC is a type of inflammatory bowel disease (IBD) that affects the lining of the large intestine (colon) and rectum.
UC是一种类型炎症性肠道病(IBD)，影响大肠(结肠)和直肠衬里。
Inflammatory bowel disease (IBD) is chronic recurrent intestinal inflammatory disorders, including ulcerative colitis and Crohn's disease.
炎症性肠病(IBD)是一组反复发作的肠道慢性炎症性疾病，包括溃疡性结肠炎和克罗恩病。
But we also have the highest rates of inflammatory bowel disease, or ibd-when the immune system mistakenly attacks intestinal cells and friendly gut bacteria.
但我们感染上炎症性疾病(简称IBD)的概率仍然很高，因为免疫系统会错把肠道细胞和友好的肠道细菌当做攻击对象。
Objective: to evaluate the monitoring action of the expression myeloperoxidase (MPO) and superoxide dismutase (SOD) activity in the active inflammatory bowel disease (IBD).
目的：研究髓过氧化物酶(MPO)和超氧化物歧化酶(SOD)活性在监测炎症性肠病(IBD)病情活动中的作用。
Objective to evaluate the monitoring action of the expression myeloperoxidase (MPO) and superoxide dismutase (SOD) activity in the active inflammatory bowel disease (IBD).
目的探讨髓过氧化物酶(MPO)和超氧化物歧化酶(SOD)作为炎症性肠病(IBD)病情活动临床监测指标的价值。
Crohn s disease and ulcerative colitis, collectively known as inflammatory bowel disease (IBD), the etiology is not clear, but its pathogenesis has had more understanding.
克罗恩病和溃疡性结肠炎统称为炎症性肠病(IBD)，病因虽不明确，但对其发病机理已有了较多的了解。
While there can be other, more acute and short term causes of these symptoms, when they become more frequent and chronic then the diagnosis of Inflammatory Bowel Disease (IBD) needs to be explored.
虽然可以有其他，更加尖锐，短期内这些症状的原因，当他们变得更加频繁和慢性炎症性肠病(IBD)的诊断需要探索。
Objective to analyze and examine the characteristics and roles of extra-intestinal manifestations accompanied with inflammatory bowel disease (IBD).
目的分析并探讨炎症性肠病(IBD)患者肠外表现的特点和临床意义。
Objective to screen the risk factors of inflammatory bowel disease (IBD) by case investigation.
目的通过病例调查，筛选IBD的危险因素。
OBJECTIVE: to investigate status quo of pharmacogenetics of inflammatory bowel disease (IBD), in order to provide some references for rational use of such kinds of drugs in the clinic.
目的：了解炎症性肠病药物遗传学的现状，为该类药物在临床的合理应用提供参考。
The etiological factors and mechanism of inflammatory bowel disease (IBD) are not clear yet.
炎症性肠病(IBD)的病因和发病机制至今仍未完全明确。
Objective:To observe the efficacy and safety of Etiasa, a control released tablet of mesalazine, in treatment of inflammatory bowel disease(IBD) in comparison with salicylazosulfapyridine (SASP).
目的：观察一种新型美沙拉嗪控释剂（艾迪莎）治疗炎症性肠病（IBD）的疗效和安全性，并同水杨酸偶氮磺胺吡啶（SASP）进行比较。
Inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn's disease are chronic, life-long, and relapsing diseases of the gastrointestinal tract.
炎症性肠病是一种慢性的、反复发作的、终身性的胃肠道疾病，包括溃疡性结肠炎和克罗恩病。
Doctor: : According to the results, you're diagnosed as ulcerative colitis, which is one type of inflammatory bowel disease, IBD for short.
医生：根据你的检查结果，可以确定你得的是溃疡性结肠炎，属于炎症性肠病的一种，炎症性肠病简称IBD。
Doctor: : IBD, also known as inflammatory bowel disease, is a chronic and unspecific inflammatory intestinal conditions, including ulcerative colitis and Crohn's disease.
医生：IBD，又称炎症性肠病，是一种慢性非特异性肠道炎症性疾病，包括溃疡性结肠炎和克罗恩病。
Doctor: : IBD, also known as inflammatory bowel disease, is a chronic and unspecific inflammatory intestinal conditions, including ulcerative colitis and Crohn's disease.
医生：IBD，又称炎症性肠病，是一种慢性非特异性肠道炎症性疾病，包括溃疡性结肠炎和克罗恩病。
应用推荐